DaVita HealthCare Partners Inc. (DVA) Holdings Raised by Meag Munich Ergo Kapitalanlagegesellschaft MBH

Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its position in DaVita HealthCare Partners Inc. (NYSE:DVA) by 1,987.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 41,746 shares of the company’s stock after purchasing an additional 39,746 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft MBH’s holdings in DaVita HealthCare Partners were worth $2,448,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in DVA. PGGM Investments purchased a new stake in shares of DaVita HealthCare Partners in the 2nd quarter valued at approximately $28,598,000. Canada Pension Plan Investment Board increased its position in shares of DaVita HealthCare Partners by 33.1% in the 2nd quarter. Canada Pension Plan Investment Board now owns 387,370 shares of the company’s stock valued at $25,086,000 after purchasing an additional 96,282 shares during the last quarter. Speece Thorson Capital Group Inc. increased its position in shares of DaVita HealthCare Partners by 14.5% in the 3rd quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock valued at $19,075,000 after purchasing an additional 40,667 shares during the last quarter. Airain ltd purchased a new stake in shares of DaVita HealthCare Partners in the 2nd quarter valued at approximately $2,234,000. Finally, Oak Associates Ltd. OH increased its position in shares of DaVita HealthCare Partners by 21.1% in the 2nd quarter. Oak Associates Ltd. OH now owns 185,195 shares of the company’s stock valued at $11,993,000 after purchasing an additional 32,285 shares during the last quarter. 84.73% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION WARNING: “DaVita HealthCare Partners Inc. (DVA) Holdings Raised by Meag Munich Ergo Kapitalanlagegesellschaft MBH” was first reported by Stock Observer and is the property of of Stock Observer. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.thestockobserver.com/2017/11/14/davita-healthcare-partners-inc-dva-holdings-raised-by-meag-munich-ergo-kapitalanlagegesellschaft-mbh.html.

DaVita HealthCare Partners Inc. (DVA) opened at $54.99 on Tuesday. DaVita HealthCare Partners Inc. has a twelve month low of $52.51 and a twelve month high of $70.16. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.40 and a quick ratio of 1.35. The stock has a market cap of $10,407.74, a price-to-earnings ratio of 15.71, a PEG ratio of 11.05 and a beta of 0.98.

DaVita HealthCare Partners (NYSE:DVA) last issued its earnings results on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.13). DaVita HealthCare Partners had a net margin of 3.40% and a return on equity of 13.31%. The company had revenue of $3.92 billion during the quarter, compared to analyst estimates of $3.91 billion. During the same quarter in the previous year, the company posted $0.95 EPS. The company’s quarterly revenue was up 5.2% on a year-over-year basis. sell-side analysts expect that DaVita HealthCare Partners Inc. will post 3.43 earnings per share for the current year.

DaVita HealthCare Partners announced that its Board of Directors has authorized a share buyback program on Tuesday, October 10th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s board of directors believes its shares are undervalued.

A number of brokerages have commented on DVA. KeyCorp reissued a “hold” rating on shares of DaVita HealthCare Partners in a research report on Monday. Robert W. Baird reissued a “hold” rating and issued a $63.00 price objective on shares of DaVita HealthCare Partners in a research report on Friday. Bank of America Corporation dropped their price objective on shares of DaVita HealthCare Partners from $75.00 to $66.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 8th. Royal Bank Of Canada lowered their target price on shares of DaVita HealthCare Partners from $64.00 to $60.00 and set a “sector perform” rating for the company in a report on Wednesday, November 8th. Finally, Wolfe Research upgraded shares of DaVita HealthCare Partners from a “market perform” rating to an “outperform” rating in a report on Monday, October 23rd. Four equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company’s stock. DaVita HealthCare Partners currently has a consensus rating of “Hold” and a consensus price target of $63.00.

DaVita HealthCare Partners Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita HealthCare Partners Inc. (NYSE:DVA).

Institutional Ownership by Quarter for DaVita HealthCare Partners (NYSE:DVA)

Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply